South Korea Blood-based Biomaker For Sports Medicine Market Size & Outlook

The blood-based biomaker for sports medicine market in South Korea is expected to reach a projected revenue of US$ 19.2 million by 2030. A compound annual growth rate of 7.5% is expected of South Korea blood-based biomaker for sports medicine market from 2024 to 2030.
Revenue, 2023 (US$M)
$11.6
Forecast, 2030 (US$M)
$19.2
CAGR, 2024 - 2030
7.5%
Report Coverage
South Korea

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea blood-based biomaker for sports medicine market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

South Korea blood-based biomaker for sports medicine market highlights

  • The South Korea blood-based biomaker for sports medicine market generated a revenue of USD 11.6 million in 2023 and is expected to reach USD 19.2 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
  • In terms of segment, ck was the largest revenue generating type in 2023.
  • CRP is the most lucrative type segment registering the fastest growth during the forecast period.


Blood-based biomaker for sports medicine market data book summary

Market revenue in 2023USD 11.6 million
Market revenue in 2030USD 19.2 million
Growth rate7.5% (CAGR from 2023 to 2030)
Largest segmentCk
Fastest growing segmentCRP
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.7% of the global blood-based biomaker for sports medicine market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.

Ck was the largest segment with a revenue share of 18.1% in 2023. Horizon Databook has segmented the South Korea blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.


South Korea is witnessing a rise in sports-related injuries, particularly among elite athletes. According to a National Institutes of Health (NIH) report from February 2021, around 782 elite athletes participated in 46 sporting events, with 141 injuries recorded, representing an injury rate of 18.03%. Of these injuries, 121 athletes (15.47%) experienced at least one injury.

Male athletes accounted for 80 injuries (56.74%), while female athletes suffered 61 (43.26%). This increasing prevalence of sports injuries has heightened the demand for advanced medical solutions, including blood-based biomarkers, which are becoming an integral part of sports medicine in South Korea.

As South Korea continues to focus on the health & performance of its athletes, the market for blood-based biomarkers in sports medicine is expected to witness significant growth over the forecast period. This development reflects the country’s commitment to integrating cutting-edge medical technologies into its sports healthcare infrastructure, ensuring better care and enhanced performance for its athletes.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood-based Biomaker for Sports Medicine Market Companies

Name Profile # Employees HQ Website
RayBiotech View profile 101-250 Norcross, Georgia, United States, North America http://www.raybiotech.com/
Randox View profile 1001-5000 Crumlin, Antrim, United Kingdom, Europe http://www.randox.com
Beckman Coulter View profile 10001+ Brea, California, United States, North America http://www.beckmancoulter.com
ARUP Laboratories View profile 1001-5000 Salt Lake City, Utah, United States, North America http://www.aruplab.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

South Korea blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)

South Korea Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)

South Korea blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online